跳至主要内容
临床试验/NCT07427706
NCT07427706已完成不适用

Assessment of the Effect of Tobacco Consumption on the Health Indicators of Newborns up to 24 Months.

Institut Investigacio Sanitaria Pere Virgili1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2023年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
105
试验地点
1
主要终点
Haizea-Llevant Developmental Screening Table - Global Child Development Assessment

研究概览

简要总结

There is scientific evidence suggesting that tobacco use during pregnancy is associated with several adverse effects in newborns, including low birth weight, respiratory complications, severe neonatal morbidity, perinatal death, and a higher risk of infections and neurological problems.

Newborns of mothers who smoked during pregnancy show worse health indicators at birth and during the first years of life compared to those whose mothers quit smoking before pregnancy. The aim is to determine whether there are differences in the main health indicators between newborns whose mothers stopped smoking during pregnancy and those who were exposed to their mothers' tobacco use.

This is a retrospective descriptive study of the Tobbgest study cohort, and the study will be conducted within the Primary and Community Health care setting.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • - Newborns of participants in the Tobbgest study who provide data (CIP and/or full name) of their offspring.

排除标准

  • - Newborns who do not follow the healthy child preventive activities program or whose data is not recorded in the Primary Care Clinical Station (ECAP), the primary care computer program in Catalonia.

结局指标

主要结局

Haizea-Llevant Developmental Screening Table - Global Child Development Assessment

时间窗: from birth to 24 months

The Haizea-Llevant Developmental Table is a pediatric screening tool used to assess psychomotor development in children from birth to 5 years of age. A trained health professional conducts direct observation of the child and asks standardized questions to caregivers to verify the acquisition of developmental milestones. The instrument is organized by age in months and evaluates four domains: socialization, language and communication, fine motor manipulation, and gross motor/postural skills. Each item indicates the age range at which most children achieve the skill. If a child does not complete an expected task, earlier milestones in the same domain are assessed to determine functional level. Results are classified as normal, monitoring/risk, or suspected developmental delay, guiding follow-up or referral. It is a screening, not diagnostic, measure.

Apgar test

时间窗: 1 minut, 5 minuts and 10 minuts

The Apgar test is the first vital examination performed on a newborn in the first minutes of life. This test has proven to be very important in quickly detecting diseases or complications in the newborn and has even significantly reduced their mortality rate. Therefore, the Apgar test helps to understand the baby's condition at the time of birth. The normal Apgar score ranges are around 7-10. For example, if the Apgar score is 9/10, it means there was a change in the score between the first measurement at one minute of life and the next measurement at five minutes.

Mother's pregnancy

时间窗: Number of weeks of pregnancy. The value is usually between 20 and 42 weeks.

Weeks of gestation of the mother. From the date of the last menstrual period until the day of delivery.

weight

时间窗: 24 months

The date and the values in kilos will be included

head circumference

时间窗: 24 months

The date and values in cm will be included

height

时间窗: 24 months

The date and values in cm will be included

次要结局

  • type of delivery(time of delivery)
  • Neonatal early screening(time of delivery)
  • Newborn hearing screening(neonatal period, usually before discharge from the maternity center,)
  • Duration of breastfeeding(From enrollment to the end of follow-up, 24 months)
  • Another type of screening(From enrollment to the end of follow-up, 24 months)

研究者

发起方
Institut Investigacio Sanitaria Pere Virgili
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cristina Rey Reñones, PhD

Dr, Nurse

Institut Investigacio Sanitaria Pere Virgili

研究点 (1)

Loading locations...

相似试验